Try our Advanced Search for more refined results
Health
-
March 27, 2026
Hospital System Beats Most Of REIT's $50M Floodwall Suit
A New York federal judge on March 27 mostly tossed a real estate investment trust's $50 million suit against the New York City Health and Hospitals Corp. and the NYC Economic Development Corp. over the design of a proposed floodwall for a downtown Manhattan life sciences campus project.
-
March 27, 2026
Skincare Co. Says ITC Ruling Backs Ending PTAB Challenge
Skin products company Hydrafacial has argued U.S. Patent and Trademark Office Director John Squires should turn down a rehearing request from rival Sinclair Pharma over Squires' order de-instituting a challenge to Hydrafacial's patent, saying a U.S. International Trade Commission decision upholding the same patent supports the director's move.
-
March 27, 2026
Sens. Push Bill To Equip VA For Psychedelic Therapies
A bipartisan group of U.S. senators has introduced legislation to broaden veterans' access to emerging therapies, including psychedelic-assisted treatments, that may be effective in addressing post-traumatic stress disorder and other mental health issues.
-
March 27, 2026
Biopharma's Brass Hid Anxiety Drug Trial Risks, Investor Says
Vistagen Therapeutics' current and former top brass have been hit with a derivative shareholder suit in California federal court alleging they overstated its clinical trial for a novel, anti-anxiety drug while hiding unpredictable placebo responses and other known risks, before the phase ultimately failed, causing a stock price collapse.
-
March 27, 2026
States Suspect ICE Obtained Medicaid Data Despite Order
A coalition of states told a federal judge that the Trump administration appears to have ignored an order limiting the types of Medicaid data that can be shared with immigration officials, potentially handing over reams of "off limits" data on citizens and green card holders.
-
March 27, 2026
Biogen Beats Investor Suit Over Dozens Of Drug Claims
Biogen Inc. and four of its executives escaped a stock drop suit Friday after a Massachusetts federal judge ruled that none of the nearly five dozen statements challenged by investors suggested that the company intentionally misled people buying its stock.
-
March 27, 2026
Mississippi Gov. Vetoes Medical Marijuana Expansion Bill
Mississippi Gov. Tate Reeves has vetoed a bill to expand the state's medical cannabis program to include severely ill patients, while approving another bill to fund a clinical trial into the psychedelic ibogaine.
-
March 27, 2026
Pa. Health Network's $1.15M 401(k) Suit Deal Gets Final OK
A Pennsylvania federal judge gave the green light to a $1.15 million deal resolving a proposed class action alleging a healthcare system misused workers' forfeited employee retirement plan funds and failed to rein in administrative fees.
-
March 27, 2026
Insurer Rips Sanctions Bid In Opioid Coverage Dispute
An insurer asked an Illinois federal court to reject a drug wholesaler's bid for sanctions in a dispute over coverage for underlying opioid litigation, saying the accusations that it intentionally destroyed pertinent evidence are, "at best, based on half-truths and misstatements of fact."
-
March 27, 2026
Colo. Nurses Snag Class Cert. In Holiday Pay Case
A group of nurses can proceed as a class in a suit accusing a healthcare company of excluding holiday premiums from their pay when they worked overtime, a Colorado federal judge has ruled.
-
March 27, 2026
Hospital Escapes Ex-Workers' 401(k) Forfeiture, Fund Suit
A New York federal judge on Friday tossed a proposed class action against a healthcare company alleging mismanagement of an employee 401(k) plan, concluding that ex-workers who sued lacked standing to bring some claims while the remaining allegations weren't sufficiently backed up to state a claim for violating federal benefits law.
-
March 27, 2026
Kirkland-Led Transcend Bought By Otsuka In $1.2B Deal
Clinical-stage biotechnology company Transcend Therapeutics Inc., led by Kirkland & Ellis LLP, Pillsbury Winthrop Shaw Pittman LLP and Goodwin Procter LLP, on Friday announced that it has agreed to be bought by Otsuka Pharmaceutical Co. Ltd. in a deal worth up to $1.225 billion.
-
March 26, 2026
Ex-Mich. City Workers Say Judge Erred In Trimming Vax Suit
Former city employees of Ann Arbor, Michigan, asked a federal judge Thursday to reconsider her decision to remove religious discrimination and state civil rights claims from their suit alleging religious discrimination after they were denied COVID-19 vaccine exemptions.
-
March 26, 2026
Imaging Practice Data Breach Class Actions Hit NC Biz Court
A series of putative class actions resulting from a data breach at imaging practice Triad Radiology Associates PLLC hit North Carolina Business Court this week, with a couple of the cases naming hospitals that partnered with the practice.
-
March 26, 2026
Co. Accused Of Sharing Mental Health Data With Google
A California resident alleged in Colorado federal court that a Denver-based telehealth mental health provider is providing sensitive customer data to Google without their consent in violation of federal and state privacy laws, according to a proposed class action filed Thursday.
-
March 26, 2026
Legislative Update: Cannabis And Psychedelics Bill Roundup
Lawmakers at the state and federal level stewarded legislation to rein in kratom and its derivatives, Idaho lawmakers took a stand against a proposal to legalize medical marijuana via ballot initiative, and New York legislators introduced a plan to audit the state's cannabis regulator on an annual basis. Here are the major moves in cannabis and psychedelics legislation from the past week.
-
March 26, 2026
Pregnancy 'Crisis' Center Loses Bid To End Deception Claims
A Massachusetts federal judge on Thursday rejected a request by an anti-abortion nonprofit and a Missouri marketing firm to dismiss claims that they tried to trick women into visiting a pregnancy "crisis" center.
-
March 26, 2026
Texas Court Won't Dismiss Patient's Cancer Misdiagnosis Suit
A Texas appellate court has greenlighted a suit accusing a physician and two healthcare companies of misdiagnosing a patient with cancer, finding the plaintiff's expert report adequately outlined how the alleged negligence led to an unnecessary procedure.
-
March 26, 2026
McDonald Hopkins Must Produce Fraud Warning Docs
Midwestern law firm McDonald Hopkins LLC must produce email communications in connection with litigation accusing Blue Cross units of a smear campaign against a clinical lab owner, an Ohio federal judge ruled, finding the documents were not protected by work product or attorney-client privilege.
-
March 26, 2026
U.S. Lawmakers Renew Tribal Child Abuse Prevention Bill
A trio of U.S. lawmakers has reintroduced a bill that aims to strengthen available resources to Indigenous nations by filling gaps in the Child Abuse Prevention and Treatment Act to provide for more equitable access to grant funding opportunities.
-
March 26, 2026
DOJ Says NY-Presbyterian Blocked Lower-Cost Health Plans
New York-Presbyterian Hospital is forcing major health insurers to contract with it on an "all-or-nothing" basis, which is driving up healthcare costs in New York City and violates federal antitrust law, the U.S. Department of Justice said in a federal lawsuit filed Thursday.
-
March 26, 2026
9th Circ. Upholds Medtronic Win In Spinal Cord Device Suit
A Washington man cannot sue medical device maker Medtronic USA Inc. on allegations it sold him a spinal cord implant that malfunctioned causing greater pain, the Ninth Circuit ruled, saying he lacked expert witnesses to support his negligence claims.
-
March 26, 2026
Regeneron Can't Sink Disability Bias Claims Over Scheduling
A former Regeneron Pharmaceuticals director can proceed with her lawsuit claiming she was fired for requesting a flexible schedule to care for her daughter, a New York federal judge ruled, saying she'd sufficiently backed up allegations that doing so had violated federal disability bias law.
-
March 26, 2026
IOC Bans Transgender Athletes From Women's Competitions
The International Olympic Committee announced a ban Thursday on transgender athletes competing in women's events, a policy shift that will see Olympic hopefuls subjected to genetic testing to determine their eligibility.
-
March 25, 2026
Law Firm Ransomware Attacks On Rise, Report Says
Cyberattacks targeting law firms jumped in 2025, according to a new BakerHostetler report, which also highlighted recent spikes across a wide range of sectors in ransomware payments and class action lawsuits stemming from these incidents.
Expert Analysis
-
How Cos. Can Prep For Tightened Calif. Data Breach Notices
Amid California's recent enactment of S.B. 446, which significantly amends the state's data breach notification laws, companies should review and update their incident response plans by establishing processes to document and support any delayed notification, and ensure the notifications' accuracy, say Mark Krotoski and Alexandria Marx at Pillsbury.
-
Employer Considerations After 11th Circ. Gender Care Ruling
The Eleventh Circuit's en banc decision in Lange v. Houston County, Georgia, finding that a health plan did not violate Title VII by excluding coverage for gender-affirming care, shows that plans must be increasingly cognizant of federal and state liability as states pass varying mandates, say attorneys at Miller & Chevalier.
-
Series
The Biz Court Digest: How It Works In Massachusetts
Since its founding in 2000, the Massachusetts Business Litigation Session's expertise, procedural flexibility and litigant-friendly case management practices have contributed to the development of a robust body of commercial jurisprudence, say James Donnelly at Mirick O’Connell, Felicia Ellsworth at WilmerHale and Lisa Wood at Foley Hoag.
-
How Healthcare Practices Can Prepare For ICE Visits
Healthcare providers that may face encounters with immigration enforcement should familiarize themselves with compliance obligations beyond ensuring employment authorization, and mitigate risk by establishing clear policies and specific procedures that safeguard patient rights and manage staff interactions with agents, say attorneys at Roetzel & Andress.
-
Adapting To Calif.'s Enhanced Regulation Of PE In Healthcare
New California legislation enhances oversight on the role of private equity groups and hedge funds in healthcare transactions, featuring both a highly targeted nature and vague language that will require organizations to carefully evaluate existing practices, says Andrew Demetriou at Husch Blackwell.
-
Why Appellees Should Write Their Answering Brief First
Though counterintuitive, appellees should consider writing their answering briefs before they’ve ever seen their opponent’s opening brief, as this practice confers numerous benefits related to argument structure, time pressures and workflow, says Joshua Sohn at the U.S. Department of Justice.
-
Navigating DEA Quotas: Key To Psychedelics Industry Growth
As new compounds like DOI enter the Schedule I landscape, manufacturers who anticipate U.S. Drug Enforcement Administration quota regulations, and build quota management into their broader strategy, will be best equipped to meet the growing demand, say Kimberly Chew at Husch Blackwell and Jaime Dwight at Promega.
-
Federal Acquisition Rules Get Measured Makeover
The Trump administration's promised overhaul of the Federal Acquisition Regulation is not a revolution in rules, but a meaningful recalibration of procurement practice that gives contracting officers more space to think, to tailor and to try, say attorneys at Mayer Brown.
-
Series
Mindfulness Meditation Makes Me A Better Lawyer
Mindful meditation enables me to drop the ego, and in helping me to keep sight of what’s important, permits me to learn from the other side and become a reliable counselor, says Roy Wyman at Bass Berry.
-
Lessons From 7th Circ. Decision Affirming $183M FCA Verdict
The Seventh Circuit's decision to uphold a $183 million False Claims Act award against Eli Lilly engages substantively with recurring materiality and scienter questions and provides insights into appellate review of complex trial court judgments, say Ellen London at London & Naor, Li Yu at Bernstein Litowitz and Kimberly Friday at Osborn Maledon.
-
AI Litigation Tools Can Enhance Case Assessment, Strategy
Civil litigators can use artificial intelligence tools to strengthen case assessment and aid in early strategy development, as long as they address the risks and ethical considerations that accompany these uses, say attorneys at Barnes & Thornburg.
-
Attys Beware: Generative AI Can Also Hallucinate Metadata
In addition to the well-known problem of AI-generated hallucinations in legal documents, AI tools can also hallucinate metadata — threatening the integrity of discovery, the reliability of evidence and the ability to definitively identify the provenance of electronic documents, say attorneys at Law & Forensics.
-
Calif. Justices Continued Anti-Arbitration Trend This Term
In the 2024-2025 term, the California Supreme Court justices continued to narrow arbitration's reach under state law, despite state courts' extreme caseload backlog and even as they embraced contractual autonomy in other contexts, says Josephine Petrick at The Norton Law Firm.
-
Steps For Healthcare Providers After Cigna ERISA Settlement
Following the Cigna class action's settlement, where Employee Retirement Income Security Act violations arose from Cigna's online provider directory advertising providers as in-network who were actually out-of-network, providers should routinely audit their contract status and directory listings, and proactively coordinate with plans and payor partners, say attorneys at ArentFox Schiff.
-
DOJ's UnitedHealth Settlement Highlights New Remedies Tack
The use of divestitures and Hart-Scott-Rodino Act compliance in the recent U.S. Department of Justice settlement with UnitedHealth Group and Amedisys underscores the DOJ Antitrust Division's willingness to utilize merger remedies under the second Trump administration, say attorneys at Buchanan Ingersoll.